Biotechnology Stocks I Performance Guide: Cerevel Therapeutics Holdings, Inc. (CERE)
CERE has no dividends
Table and Chart of CERE Performance
See what a $1,000 investment in CERE is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| CERE Returns | |
|---|---|
| Start Date | Nov-30-2020 |
| Start Price | $14.12 |
| End Date | Dec-01-2023 |
| End Price | $26.00 |
| # Prices | 38 |
| Min Date | Jan-29-2021 |
| Min Price | $12.87 |
| Max Date | Oct-29-2021 |
| Max Price | $40.65 |
| Total Return | 84.14% |
| Annualized Return | 21.26% |
| Current Value of $1,000 Purchase | $1,841 |
| Number Returns | 703 |
| Average Return | 29.16% |
| Number Profitable Returns | 418 |
| Percent Profitable Returns | 59.46% |
| Number Unprofitable Returns | 285 |
| Percent Unprofitable Returns | 40.54% |
| Profitable to Unprofitable Returns Ratio | 1.47 |
| CERE Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $4,687,228,000 | Price to Sales |
| Earnings per Share | $-2.5000 |
| PE Ratio | None |
| PE to Growth Ratio | None |
| Price to Book | 17.17 |
| PRICE DATA | |
| 52 Week High | $35.98 |
| 52 Week Low | $19.59 |
| Analyst Target Price | $33.36 |
| 50-Day Moving Average | $23.34 |
| 200-Day Moving Average | $26.62 |
| FINANCIAL DATA | |
| Revenue per Share | $0 |
| Revenue | $0 |
| Profit Margin | 0% |
| Return on Equity | -0.897% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
CERE Compare Returns with S&P 500
CERE Trendline Chart